NCT00773747 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 317
- group Id
- BG001
- value
- 320
- group Id
- BG002
- value
- 637
- units
- Participants
- groups
- description
- Participants will receive vorinostat four 100 mg capsules (400 mg total) orally 0-30 minutes after a meal on Days 1 through 14 of a 21-day treatment cycle and bortezomib 1.3 mg/m\^2 by intravenous injection on Days 1, 4, 8, and 11 of a 21-day treatment cycle.
- id
- BG000
- title
- Vorinostat + Bortezomib
- description
- Participants will receive four placebo capsules orally 0-30 minutes after a meal on Days 1 through 14 of a 21-day treatment cycle and bortezomib 1.3 mg/m\^2 by intravenous injection on Days 1, 4, 8, and 11 of a 21-day treatment cycle.
- id
- BG001
- title
- Placebo + Bortezomib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.0
- value
- 60.9
- group Id
- BG001
- spread
- 10.0
- value
- 62.7
- group Id
- BG002
- spread
- 10.0
- value
- 61.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- In utero
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Preterm newborn infants (gestational age < 37 wks)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Newborns (0-27 days)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Infants and toddlers (28 days-23 months)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Children (2-11 years)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Adolescents (12-17 years)
- measurements
- group Id
- BG000
- value
- 200
- group Id
- BG001
- value
- 181
- group Id
- BG002
- value
- 381
- title
- Adults (18-64 years)
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 137
- group Id
- BG002
- value
- 253
- title
- From 65-84 years
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- 85 years and over
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 134
- group Id
- BG002
- value
- 260
- title
- Female
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 186
- group Id
- BG002
- value
- 377
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 285
- group Id
- BG001
- value
- 297
- group Id
- BG002
- value
- 582
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 317
- group Id
- BG001
- value
- 320
- group Id
- BG002
- value
- 637
- units
- Participants
- groups
- description
- Participants will receive vorinostat four 100 mg capsules (400 mg total) orally 0-30 minutes after a meal on Days 1 through 14 of a 21-day treatment cycle and bortezomib 1.3 mg/m\^2 by intravenous injection on Days 1, 4, 8, and 11 of a 21-day treatment cycle.
- id
- BG000
- title
- Vorinostat + Bortezomib
- description
- Participants will receive four placebo capsules orally 0-30 minutes after a meal on Days 1 through 14 of a 21-day treatment cycle and bortezomib 1.3 mg/m\^2 by intravenous injection on Days 1, 4, 8, and 11 of a 21-day treatment cycle.
- id
- BG001
- title
- Placebo + Bortezomib
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.0
- value
- 60.9
- group Id
- BG001
- spread
- 10.0
- value
- 62.7
- group Id
- BG002
- spread
- 10.0
- value
- 61.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- In utero
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Preterm newborn infants (gestational age < 37 wks)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Newborns (0-27 days)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Infants and toddlers (28 days-23 months)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Children (2-11 years)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Adolescents (12-17 years)
- measurements
- group Id
- BG000
- value
- 200
- group Id
- BG001
- value
- 181
- group Id
- BG002
- value
- 381
- title
- Adults (18-64 years)
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 137
- group Id
- BG002
- value
- 253
- title
- From 65-84 years
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- 85 years and over
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 134
- group Id
- BG002
- value
- 260
- title
- Female
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 186
- group Id
- BG002
- value
- 377
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 285
- group Id
- BG001
- value
- 297
- group Id
- BG002
- value
- 582
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle